Interaction of some Pd(II) complexes with Na⁺/K⁺-ATPase: Inhibition, kinetics, prevention and recovery

References

• Lingrel JB, Kuntzweiler T. Na+,K+-ATPase. J Biol Chem 1994; 269: 19659–19662
   PubMed Web of Science ®Google Scholar
• Mobasheri A, Avila J, Cozar-Castellano I, Brownleader MD, Trevan M, Francis MJO, Lamb JF, Martin-Vasallo P. Na+,K++-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep 2000; 20: 51–91
   PubMed Web of Science ®Google Scholar
• Krstić D, Krinulović K, Joksić G, Momić T, Vasić V. Effects of digoxin and gitoxin on the enzymatic activity and kinetic parameters of Na+/K+-ATPase. J Enz Inhib Med Chem 2004; 19: 409–415
   PubMed Web of Science ®Google Scholar
• Vasić V, Jovanović D, Krstić D, Nikezić G, Horvat A, Vujisić LJ, Nedeljković N. Prevention and recovery of CuSO4 induced inhibition of Na,K-ATPase and Mg-ATPase in rat brain synaptosomes by EDTA. Toxicol Lett 1999; 110: 95–104
   PubMed Web of Science ®Google Scholar
• Vasić V, Krinulović K, Krstić D, Momić T, Horvat A. ATPases as multi-response sensing system for various organic and inorganic analytes. Monatsch Chem 2004; 135: 605–614
   Google Scholar
• Vujisić LJ, Krstić D, Krinulović K, Vasić V. The influence of transition and heavy metal ions on ATP-ases activity in rat synaptic plasma membranes. J Serb Chem Soc 2004; 69: 541–547
   Google Scholar
• Carfagna MA, Ponsler GD, Muhoberac BB. Inhibition of ATPase activity in rat synaptic plasma membranes by simultaneous exposure to metals. Chem Biol Interact 1996; 100: 53–65
   PubMed Web of Science ®Google Scholar
• Boldyrev A, Bulygina E, Kramarenko G, Vanin A. Effect of nitroso compounds on Na/K-ATPase. Biochim Biophys Acta 1997; 1321: 243–251
   PubMed Web of Science ®Google Scholar
• Nechay BR, Neldon SL. Characteristics of inhibition of human renal adenosine triphosphatases by cisplatin and chloroplatinic acid. Cancer Treat Rep 1984; 68: 1135–1141
   PubMedGoogle Scholar
• Louie AY, Meade TJ. Metal complexes as enzyme inhibitors. Chem Rev 1999; 99: 2711–2734
   PubMed Web of Science ®Google Scholar
• Jakupec MA, Galanski M, Keppler BK. Tumour-inhibiting platinum complexes–state of the art and future perspectives. Rev Physiol Biochem Pharmacol 2003; 146: 1–54
   PubMed Web of Science ®Google Scholar
• Lippert B. Cisplatin, chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Zürich 1999
   Google Scholar
• Reedijk J. Why does cisplatin reach Guanine-N7 with competing S-donor ligands available in the cell?. Chem Rev 1999; 99: 2499–2510
   PubMed Web of Science ®Google Scholar
• Djuran MI, Dimitrijević DP, Milinković SU, Bugarčić ŽD. Reactions of platinum(II)complexes with sulfur-and histidine-containing peptides: A model for selective platination of peptides and proteins. Trans Metal Chem 2002; 27: 155–158
   Google Scholar
• Sakakibara N, Suzuki K, Kaneta H, Yoshimura Y, Deyama Y, Matsumoto A, Fukuda H. Inhibition of Na+,K+-ATPase by cisplatin and its recovery by 2-mercaptoethanol in human squamous cell carcinoma cells. Anticancer Drugs 1999; 10: 203–211
   PubMed Web of Science ®Google Scholar
• Uozumi J, Litterst CL. The effect of cisplatin on renal ATPase activity in vivo and in vitro. Cancer Chemother Pharmacol 1985; 15: 93–96
   PubMed Web of Science ®Google Scholar
• Rau T, van Eldik R. Interactions of metal ions with nucleotides, nucleic acids, and their constituents. Metal ions in biological systems, A Sigel, H Sigel. Marcel Dekker, New York 1996; 32: 339–378
   Google Scholar
• Bugarčić ŽD, Liehr G, van Eldik R. Kinetics and mechanism of the reaction of chelated Pd(II) complexes with thiols in acidic aqueous solution. Synthesis and crystal structure of [Pd(bpma)Cl]Cl√H2O (bpma = bis(2-pyridylmethyl)amine). J Chem Soc Dalton Trans 2002; 951–956
   Google Scholar
• Vasić V, Čakar M, Savić J, Petrović B, Nedeljković J, Bugarčić Ž. Influence of sodium dodecyl sulfate on the kinetics of complex formation between [PdCl(dien)]+ and sulfur containing ligands l-cysteine and glutathione. Polyhedron 2003; 22: 279–285
   Google Scholar
• Vasić VM, Živanović MA, Čakar MM, Savić JZ, Nedeljković JM, Bugarčić ŽD. Influence of acidity on the reaction between [PdCl(dien)]+ and l-cysteine or glutathione in the presence of sodium dodecyl sulfate micelles. J Phys Org Chem 2005; 18: 441–447
   Web of Science ®Google Scholar
• Bugarcic ZD, Jancic DM, Shoukry AA, Shoukry MM. Rate and equilibrium data for substitution reactions of [Pd(dien)Cl]+with l-Cysteine and glutathione in aqueous solution. Monatsch Chem 2004; 135: 151–160
   Web of Science ®Google Scholar
• Bugarčić ŽD, Heinemann FW, van Eldik R. Substitution reactions of [Pt(terpy)X]2+ with some biologically relevant ligands. Synthesis and crystal structure of [Pt(terpy)(cyst-S)](ClO4)2·0.5H2O and [Pt(terpy)(guo-N7)](ClO4)2·0.5guo ·1.5H2O. J Chem Soc Dalton Trans 2004; 279–286
   Google Scholar
• Clausen AE, Kast C, Bernkop-Schnürch E. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharmac Res 2002; 19: 602–608
   PubMed Web of Science ®Google Scholar
• Rabenstein DL, Guevremont R, Evans CA. Glutathione and its metal complexes. Metal ions in biological systems, H Sigel. Marcel Dekker, New York 1979; Vol. 9: 103–107
   Google Scholar
• Hussain S, Anner RM, Anner BM. Cysteine protects Na,K-ATPase and isolated human lymphocytes from silver toxicity. Biochem Biophys Res Commun 1992; 189: 1444–1449
   PubMed Web of Science ®Google Scholar
• Henderson GB, Fairlamb AH, Ulrich P, Cerami A. Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata. Biochemistry 1987; 26: 3023–3027
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Mastrolorenzo A, Supuran CT. Agents that target cysteine residues of biomolecules and their therapeutic potential. Expert Opin Ther Pat 2001; 11: 765–787
   Web of Science ®Google Scholar
• Scozzafava A, Casini A, Supuran CT. Targeting cysteine residues of biomolecules: New approaches for the design of antiviral and anticancer drugs. Curr Med Chem 2002; 9: 1167–1185
   PubMed Web of Science ®Google Scholar
• Breet ELJ, van Eldik R. The isolation and identification of an unusual palladium(II) substituted dien complex [1]. Inorg Chim Acta 1983; 76: L301–L303
   Web of Science ®Google Scholar
• Philips TD, Hayes AW, Ho IK, Desiah D. Effects of rubrotoxinB on the kinetics of cationic and substrate activation of Na,K-ATPase and p-nitrophenylphosphetase. J Biol Chem 1978; 253: 3487–3493
   PubMedGoogle Scholar
• Vasić V, Jovanović D, Horvat A, Momić T, Nikezić G. Effect of Cd2+and Hg2+ on the activity of Na+/K+-ATPase and Mg2+-ATPase adsorbed on polystyrene microtiter plates. Anal Biochem 2002; 300: 113–120
   PubMed Web of Science ®Google Scholar
• Garrett RH, Grisham CM. Biochemistry2nd edition. Harcourt Brace, Orlando; Florida 1999; 443–447
   Google Scholar
• Al-Jafari AA, Kamal MA, Greig NH, Alhomida AS, Perry ER. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: Phenserine. Biochem Biophys Res Comm 1998; 248: 180–185
   PubMedGoogle Scholar
• Neault JF, Benkirane A, Malonga H, Tajmir-Riahi HA. Interaction of cisplatin drug with Na,K-ATPase: Drug binding mode and protein secondary structure. Drug J Inorg Biochem 2001; 86: 603–609
   PubMed Web of Science ®Google Scholar
• Friedman M. The chemistry and biochemistry of the sulfhydryl group. Amino acids, peptides and proteins. Pergamon Press, New York 1973; 52–87
   Google Scholar
• Krstić D, Krinulović K, Vasić V. Inhibition of Na+/K+-ATPase and Mg2+-ATPase by metal ions and prevention and recovery of inhibited activities by chelators. J Enz Inhib Med Chem 2005; 20: 469–476
   PubMed Web of Science ®Google Scholar